Panels and Meetings

The OneMed Conference brings together leading experts in emerging healthcare companies with the ongoing mission of providing unparalleled insight for investors. Our 30-minute “speed panels” are designed to create an opportunity for direct networking. Panel transcripts will anchor our proprietary Sector Reports along with profiles of promising ventures that will be presenting at the OneMedForum.

 

Monday, January 12th 2015

Monday, January 12th Schedule

Monday, January 12, 2015  

7:30 am   Registration opens

8:30 am   Company presentations and Workshops

                  OneMedConnect Partnering Opens

12:30 pm Networking Luncheon

  5:30 pm Welcoming Reception 

 

 

 

Tuesday, January 13, 2015  

7:30 am   Registration 

8:30 am   Company presentations and Workshops 

                    OneMedConnect Partnering

12:30 pm Networking Luncheon

  5:30 pm Reception 

Tuesday, January 13th Schedule
  • 9:30 AM - 10:00 AM
    Opportunities in China
    The rapid economic growth of China has created a large number of entrepreneurial success stories, many of which have been in healthcare. These companies have significant capital resources and are seeking innovative biomedical technologies to support their continued growth. The Chinese economy is hungry for promising products and technologies and has begun looking to North America and Europe to expand their pipeline. Our panel will offer perspectives on how to successfully approach this vast market. We will discuss deal structure alternatives for companies looking to secure capital, as well as licensing and distribution opportunities. With the right structure, US healthcare and life science companies can monetize their technology with little risk or cost.

  • 10:30 AM - 11:00 AM
    Israeli Technologies
    Israel has long been a hub of innovation in the healthcare and life sciences field. This panel will explore recent trends in the Israeli healthcare tech industry and showcase some groundbreaking innovations. A focus will be placed on Israeli companies seeking to enter the North American market through joint ventures, distribution and licensing agreements.

  • 12:30 PM
    Networking Luncheon


  • 2:00 PM - 2:30 PM
    Digital Health
    As smart devices evolve into advanced applications, they continue to command increasingly important roles in the healthcare industry. Connectivity and transparency are slowly making way into the healthcare system as consumers are take greater control of health information. As a result, business models in healthcare delivery are changing.

  • 3:00 PM - 3:30 PM
    Oncology
    Advances in cancer diagnosis and treatment are growing at a rapid pace. Targeted therapies and innovative new drugs are seeking to reach the market. Panelists will provide an overview of major developments in the diagnosis, monitoring, and treatment of cancer.

  • 4:45 PM - 5:30 PM
    Private Company Finance: The 401K as a Source of Patient Venture Capital
    "How to Build a $500 Million Company in Silicon Valley without Silicon Valley" is the subject for the closing panel of day one. Based on a newly produced University of California Berkeley study on Self Directed IRA accounts and 401k as a source of Venture Capital.  The study’s author, Richard Swart PhD, and the innovator, Larry Gerrans, Founder of Sanovas, Inc. will share the model and discuss the possibilities for ‘Innovation Capital’ in the Life Sciences. Developed by Gerrans to fund his company, this unique approach used an internally run investor relations function to raise $30 million from over 300 accredited investors by tapping into the vast assets held in 401(k) and IRA plans that get little or no attention by plan managers. Sanovas is pioneering minimally invasive devices and biotechnologies across the surgical spectrum. An independent valuation agency placed a $500 million valuation on the 4 year old company. UC Berkeley’s Program for Innovation in Entrepreneurial and Social Finance at the Coleman Fung Institute who felt this approach was significant and produced a study to will be published in January 2015. This panel will be the first presentation of the Study. 
     

  • 5:30 PM
    Welcoming Reception

Tuesday, January 13th 2015

January 14-15th: China Forum V
  • 10:30 AM - 11:00 AM
    Regenerative Medicine
    In this "Extending Life and Limb" workshop, experts will discuss the most important developments in the stem cell and regenerative medicine space. With innovation set at its current pace, breakthroughs in the management of an aging population are just on the horizon.

  • 11:30 AM - 12:00 PM
    Health Data and Information Management
    An estimated 400,000 people die each year in the United States from medical errors. Adopting superior and more effective methods in the management of health information has the capacity to dramatically reduce costs and medical errors. New approaches and innovations to coordinated care offer hope in addressing this significant problem. This session will discuss some of the most important developments for the “Hospital of the Future.”

  • 12:30 PM
    Networking Luncheon

  • 2:00 PM - 2:30 PM
    Cardiology and Heart Failure
    Over 250,000 Americans die each year from heart failure. A panel will perform an overview of the innovations that have the potential to change the cardiology space, including the use of new drugs, treatments, and devices as they near approval.

  • 3:00 PM - 3:30 PM
    Neurology and Brain Health
    As innovation grows rapidly and paradigms shift, emerging companies are developing less expensive and invasive ways to diagnose and treat neurological diseases, including progressions in the mapping, imaging and modeling of the brain and CNS. This session will provide an overview to the major areas of expansion in neurology, including new diagnostic tools and technologies.

  • 4:45 PM - 5:30 PM
    Public Company Finance: Making Stock Markets Work for Entrepreneurs
    2015 is likely to see an avalanche of change impacting institutional investors, public companies and venture capitalists. From Reg. A+ (“IPO Lite”) to the SEC’s pilot to increase aftermarket support to potentially a new type of stock market (“Venture Exchanges”).  Come hear what those active in Washington believe are essential changes for the health and well-being of entrepreneurship, innovation and job growth in America.  Stephen Holmes – Member of the SEC’s Investor Advisory Committee and their “Market Structure Subcommittee.”  Scott Kupor - Co-Chairman of the Equity Capital Formation Task Force Report to the US Treasury.  Scott is a General Partner and COO of Andreessen Horowitz.   David Weild - “The Father of the JOBS Act” – The most important pro-capital formation legislation in a generation. David is the Founder & CEO of IssuWorks and a former vice chairman of The Nasdaq Stock Market
     

  • 5:30 PM
    Closing Reception